Suchergebnisse

Signatures: A-I², K². ; Wing ; Mode of access: Internet. ; MU: Pre-1801 imprint.

Signatures: A-E². ; Text in Gothic type. ; Wing ; Mode of access: Internet. ; MU: Pre-1801 imprint.

UMC copy has handwritten page nos. 176-187. ; Signatures: A-G². ; Title within decorative border; title vignette. ; Mode of access: Internet. ; MU: Pre-1801 imprint.

Signatures: A-I², K-Q². ; Text of the act followed by: A book of values of merchandize imported, according to which excise is to be paid by the first buyer; p. [17]-61. ; Wing ; Mode of access: Internet. ; MU: Pre-1801 imprint.

Text in Gothic script. ; Title within double line border. ; "Wednesday the 5th of October, 1653. Ordered by the Parliament, that this act be forthwith printed and published. Hen: Scobell, Clerk of the Parliament." ; Signatures: Y-Z⁴, A⁴. ; Wing ; Mode of access: Internet. ; MU: Pre-1801 imprint.

Signatures: 2I². ; "Friday the fourth of November, 1653. Ordered by the Parliament, that this act be forthwith printed and published. Hen: Scobell, Clerk of the Parliament." ; Imprint and statement of responsibility from colophon. ; Caption title. ; Mode of access: Internet. ; MU: Pre-1801 imprint.

"Friday the 21 of October, 1653. Ordered by the Parliament, that this act forthwith be printed and published. Hen: Scobell, Clerk of the Parliament." ; Signatures: 2F². ; Imprint and statement of responsibliity from colophon. ; Caption title. ; McAlpin Coll. ; Mode of access: Internet. ; MU: Pre-1801 imprint.

"Friday the 21th of October, 1653. Ordered by the Parliament, that this act be forthwith printed and published. Hen: Scobell, Clerk of the Parliament." ; Imprint from colophon. ; Signatures: 2E². ; Caption title. ; McAlpin Coll. ; Mode of access: Internet. ; MU: Pre-1801 imprint.

The European Position Statement (EUPS) expert group comprised of individuals who have been actively involved in the planning and execution of all the low dose CT (LDCT) randomised controlled European screening trials. They have argued that as lung cancer screening with LDCT saves lives, planning for implementation needs to be started by the national health organisations throughout Europe. The EUPS examined the current evidence which supports the planning for the implementation of lung cancer screening, as well as areas which require further work. One of the major areas the EUPS focused on was the management of prevalent lung nodules in CT-screening programmes, lung nodules at incident screening (newly detected) and CT-detected lung nodules in clinical practice should be managed with different protocols, due to different pre-test lung cancer probability. The EUPS provides nine recommendations and a "Call to Action" for implementation, which is naturally dependent on the outcome of the NELSON trial. Clearly, the issue is how Europe can take this forward as part of the political agenda of individual countries, as well as that of the EU Commission. An EU policy document has been developed, which focuses on the key steps in the implementation of cost effective lung cancer screening in Europe.

The European Position Statement (EUPS) expert group comprised of individuals who have been actively involved in the planning and execution of all the low dose CT (LDCT) randomised controlled European screening trials. They have argued that as lung cancer screening with LDCT saves lives, planning for implementation needs to be started by the national health organisations throughout Europe. The EUPS examined the current evidence which supports the planning for the implementation of lung cancer screening, as well as areas which require further work. One of the major areas the EUPS focused on was the management of prevalent lung nodules in CT-screening programmes, lung nodules at incident screening (newly detected) and CT-detected lung nodules in clinical practice should be managed with different protocols, due to different pre-test lung cancer probability. The EUPS provides nine recommendations and a "Call to Action" for implementation, which is naturally dependent on the outcome of the NELSON trial. Clearly, the issue is how Europe can take this forward as part of the political agenda of individual countries, as well as that of the EU Commission. An EU policy document has been developed, which focuses on the key steps in the implementation of cost effective lung cancer screening in Europe.

Signatures: [B²], C⁴ (C4 missing) ; Die Martis, 22 Octobr. 1650. Ordered by the Parliament, that this act be forthwith printed and published. Hen: Scobell, cleric. Parliamenti. ; Title within double line border; initial; black letter. ; Mode of access: Internet. ; MU: Pre-1801 imprint.

Signatures: 5F-5I⁴, 5i⁴ (5i4 missing) ; The versos of pages 611, 612, and 613 are numbered as ***. ; "26 Septembris, 1649. Ordered by the Commons assembled in Parliament, that this act be forthwith printed, and published. Hen: Scobell, Cleric. Parliamenti." ; McAlpin Coll. ; Mode of access: Internet. ; MU: Pre-1801 imprint.

Purpose: The current project sought to examine whether delivery of lung cancer risk projections (calculated using the Liverpool Lung Project [LLP] risk model) predicted follow-up smoking status. Design: Two single-blinded randomized controlled trials. Setting: Stop Smoking Services in Liverpool (United Kingdom). Participants: Baseline current smokers (N = 297) and baseline recent former smokers (N = 216) were recruited. Intervention: Participants allocated to intervention groups were provided with personalized lung cancer risk projections, calculated using the LLP risk model. Measures: Baseline and follow-up questionnaires explored sociodemographics, smoking behavior, and lung cancer risk perceptions. Analysis: Bivariate analyses identified significant differences between randomization groups, and logistic regression models were developed to investigate the intervention effect on the outcome variables. Results: Lung cancer risk projections were not found to predict follow-up smoking status in the trial of baseline current smokers; however, they did predict follow-up smoking status in the trial of baseline recent former smokers (odds ratio: 1.91; 95% confidence interval: 1.03-3.55). Conclusion: The current study suggests that lung cancer risk projections may help maintain abstinence among individuals who have quit smoking, but the results did not provide evidence to suggest that lung cancer risk projections motivate current smokers to quit.

"Die Martis, 9 Julii. 1650. Ordered by the Parliament, that this act be forthwith printed and published. Hen Scobell, Cleric. Parliamenti." ; "Murder of Doctor Dorislaus" --p. 913. ; Signatures: 7Z². ; Caption title. ; Wing (2nd ed.) ; Mode of access: Internet. ; MU: Pre-1801 imprint.